Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats. | Eur J Pharmacol;432(2-3): 167-75, 2001 Dec 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats.

Besse, S; Tanguy, S; Riou, B; Boucher, F; Bulteau, A L; Le Page, C; Swynghedauw, B; de Leiris, J.

Affiliation

Besse S; Laboratoire de Physiopathologie Cellulaire Cardiaque, ESA CNRS 5077, Université Joseph Fourier, Grenoble, France. Sophie.Besse@chups.jussieu.fr

Eur J Pharmacol ; 432(2-3): 167-75, 2001 Dec 07.

Article in En | MEDLINE | ID: mdl-11740953

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Aorta, Thoracic / Sulfonamides / Vasoconstriction / Myocardial Ischemia / Coronary Vessels / Hypoxia Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Aorta, Thoracic / Sulfonamides / Vasoconstriction / Myocardial Ischemia / Coronary Vessels / Hypoxia Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2001 Document type: Article Affiliation country: